← All organizations

The New York Eye Cancer Center

Academic/Hospital

Highest phase reached

Phase 1

First clinical trial

Mar 1, 2007

Last known activity

May 1, 2011

Timeline

No events for the selected filters.

Drugs by trial phase (1 distinct, 3 trials)

Phase 1 (1 own, 0 via acquisition)

Indications

Recent trials (9)

  • NCT01334879Reponsible party - principal investigatorPhase 1May 1, 2011
  • NCT01334879Overall official - principal investigatorPhase 1May 1, 2011
  • NCT01334879Lead sponsorPhase 1May 1, 2011
  • NCT00750399Reponsible party - principal investigatorPhase 1Oct 1, 2008
  • NCT00750399Overall official - principal investigatorPhase 1Oct 1, 2008
  • NCT00750399Lead sponsorPhase 1Oct 1, 2008
  • NCT00456495Reponsible party - principal investigatorPhase 1Mar 1, 2007
  • NCT00456495Overall official - principal investigatorPhase 1Mar 1, 2007
  • NCT00456495Lead sponsorPhase 1Mar 1, 2007

Details

Last known activity
May 1, 2011